In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

New Trends in Cardiovascular Drug Therapy

Add to calendar07/06/20130:00 08/06/20130:00 Europe/Paris New Trends in Cardiovascular Drug Therapy true DD/MM/YYYY

The ESC Working Group on Cardiovascular Pharmacology and Drug Therapy will hold its first congress on "New Trends in Cardiovascular Drug Therapy", from 7-8 June 2013, in the beautiful city of Rome.

The meeting will take place in the NH Vittorio Veneto Hotel, situated in the heart of the city, between the quiet grounds of Villa Borghese and the exclusive shopping and nightlife area around Via Veneto.

Those two days meeting will highlight key issues in drug therapy, with high level presentations in the field.

Preliminary Programme 


Abstract submission: closed

Preliminary programme*


Day 1Session
Pre-Congress Course
9:00- 10:30 Meet the Expert : Novel biomarkers for pharmacotherapy of atherosclerosis
Speaker: Vincenzo Mollace (Catanzaro – Roma ITALY)
10:30 – 11:00  Coffee Break
11:00 – 12:00Get with the GuidelinesPharmacotherapy in the Guidelines
Speaker: Francesco Pelliccia (Roma – ITALY)
 12:00 – 14:00  Lunch Break
 14:00-14:30 ESC Working Group on Cardiovascular Pharmacology and Drug Therapy - Opening addresses
Keld Kjeldsen (Copenhagen – DENMARK)
Giuseppe Rosano (Rome – ITALY)
 14:30-16:00  Management of Atrial Fibrillation
Chair:  Dan Atar (Oslo – NORWAY) & Maurizio Volterrani (Rome – ITALY)

Rhythm vs rate control
Francesco Pelliccia (Rome – ITALY)

Thrombotic and haemorragic risk stratification
Christian Torp –Pedersen (Aalborg – DENMARK)

Anticoagulation in Atrial Fibrillation
Felicita Andreotti (Rome – ITALY)
 16:00-16:45  Coffee break and Moderated Poster presentation
Chair: Juan Tamargo (Madrid – SPAIN)
 16:45 -17:15 Lecture
Chair: Stefan Agewall (Oslo – NORWAY)

Differences and similarities of the new oral anticoagulants
Raffele De Caterina (Chieti – ITALY)
 17:15-18:45  What is new in the management of risk factors in patients at increased cardiovascular risk
Chair: Massimo Volpe (Roma – ITALY) & Luis Ruillope (Madrid – SPAIN)

Fixed combinations in the treatment of arterial hypertension
Atul Patak (Toulouse – FRANCE)

Lipid lowering LDL and beyond
Alberto Zambon (Padua – ITALY)

Diabetes – is there any reason to prefer the newer drugs?
Juan Tamargo (Madrid – SPAIN)

Day 2Session
09:00-10:30 Pharmacological treatment of Acute Coronary Syndromes
Chair: Basil Lewis (Tel Aviv – ISRAEL)
Vincenzo Mollace (Catanzaro – Roma – ITALY)

The ESC Guidelines on Acute Coronary Syndromes
Marco Tubaro (Rome – ITALY)

How to manage triple therapy
Stefan Agewall (Oslo – NORWAY)

How to implement medical therapy at discharge
Pasquale Perrone-Filardi (Naples – ITALY)

10:30-11:00Coffee break and Chaired Poster Presentations
Francesco Pelliccia (Rome – ITALY)
11:00-12:15 Modern management of chronic ischemic heart disease

Chair Francesco Romeo (Rome – ITALY)
Heinz Drexel (Feldkirch – AUSTRIA)

Heart rate reduction 
Claudio Ceconi (Ferrara – ITALY)

Modulation of cardiac metabolism in IHD
Giuseppe Rosano (Rome – ITALY)

Optimal management of risk factors and diabetes
Sven Wassmann (Munich – Germany)

  12:15-12:45 Lecture
Chair Luis Ruillope (Madrid - SPAIN)

Putting ACE inhibitors, ARBs and Renin inhibitors into context
Roberto Ferrari (Ferrara – ITALY)

 12:45-14:00 Young Investigator Awards Presentation
Basil Lewis (Tel Aviv – ISRAEL)
 14:00-15:30 The pharmacological Heart Failure treatment
in association with the Heart Failure Association of the ESC

Chair: Faiez Zannad (Nancy – FRANCE)
Harald Schmidt (Maastricht – THE NETHERLANDS)

The HFA/ESC Guidelines on the treatment of heart failure
Stefan Anker (Berlin – GERMANY)

Devices for the management of heart failure
Sven Wassmann (Munich – GERMANY)

Pharmacotherapy in patients with devices
Atul Patak (Toulouse – FRANCE)

 15:30-17:00  Round Table discussion between Industry, Regulators and Payers
Issues in the development of cardiovascular drugs

Chair: Mihai Gheorghiade (Chicago – USA)
Giuseppe Rosano (Roma – ITALY)

Faiez Zannad (Nancy – FRANCE) – Pieter de Graeff (Amsterdam – THE NETHERLANDS) – Luca Pani (Rome – ITALY)– Michael Mendelsohn (New York – USA) – Preston Dunnmon (Washington – USA)

 17:00-17:15  Presentation of Young Investigator Award Prize
Keld Kjeldsen (Copenhagen – DENMARK)
   17:15  Closing Remarks
Giuseppe Rosano (Rome – ITALY)
Keld Kjeldsen (Copenhagen – DENMARK)

*Provisional program not confirmed by all speakers/chairmen








Early Fees
until 15 April
Standard Fees
After 15 April
Onsite Fees
 Full registration

 € 350

 € 450

  € 500

 Attendees under 35  years old
 Abstract Presenters

 € 250

 € 300


Industry representative

 € 550

 € 650

 € 800